Rich Returns vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
Ghent, Belgium returns platform for Shopify merchants; strong multi-currency, multi-language, and multi-carrier support serving international sellers underserved by US-centric returns tools.
About
Rich Returns was founded in Ghent, Belgium and built a returns management platform focused on Shopify merchants that want a clean, configurable returns portal without the pricing complexity or feature overhead of enterprise-focused competitors. The company identified a segment of the market — growing Shopify merchants in Europe and internationally — that was underserved by US-centric returns platforms and built a product with strong multi-currency, multi-language, and multi-carrier support that reflects the international nature of many Shopify merchants.\n\nThe Rich Returns platform provides a self-service customer-facing returns portal, automated return authorization workflows, carrier label generation across multiple shipping providers, and a merchant-facing returns dashboard for tracking return status and processing decisions. Merchants can configure return windows, acceptable return reasons, required evidence like photos, and resolution options including refunds, exchanges, and store credit through a non-technical admin interface.\n\nRich Returns integrates natively with Shopify and Shopify Plus, and has built carrier integrations with major European and North American shipping providers. The company competes in the emerging tier of the returns management market against Loop Returns, AfterShip Returns, and ReturnGo, differentiating through its European origin and multi-language support, competitive pricing for growing merchants, and a clean product experience that appeals to merchants who find larger platforms over-engineered for their needs.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.